What LillyDirect sells and charges
- Brand medications
- Zepbound (single-dose vial, KwikPen, single-dose pen), Foundayo, Mounjaro (type 2 diabetes label)
- Compounded GLP-1
- No
- Membership
- None (no membership; you bring your own prescription)
- Medication price from
- Zepbound from $299/month (2.5 mg vial or KwikPen, self-pay); Foundayo from $149/month
- Insurance
- Medication can go through your insurance, prior authorization handled
- How you are prescribed
- No prescriber: you bring your own prescription
- States
- Not published
Medications, insurance, prescribing and states: from the LillyDirect pages listed in Sources, read on .
Prices read from the program's own price page on . Prices change; the page you land on is the one that counts.
The public record
- FDA warning letter, : MARCS-CMS 716462: a sponsored interview video on Fox25's 'Living Oklahoma' website (July 11, 2025) promoting Zepbound through LillyDirect, found false or misleading because it omitted risk information. (source)
- FDA warning letter, : MARCS-CMS 716475: a second sponsored interview video, on Dayton247 Now's 'Your Day' website (July 9, 2025), promoting Zepbound and LillyDirect, found false or misleading because it omitted risk information. (source)
- FDA warning letter, : MARCS-CMS 716485: the ABC and Hulu special 'An Oprah Special: Shame, Blame, and the Weight Loss Revolution' found to misbrand Zepbound and Mounjaro. (source)
- State attorney general suit, : Delaware AG suit in the Court of Chancery against Eli Lilly, Novo Nordisk, Sanofi and three pharmacy benefit managers over insulin pricing. Not about LillyDirect. (source)
- State attorney general suit, : Florida AG suit under the Florida Deceptive and Unfair Trade Practices Act and Florida Antitrust Act against Eli Lilly, Novo Nordisk, Sanofi, three PBMs and rebate aggregators over insulin and diabetes-drug pricing, including some GLP-1 products. Not about LillyDirect. (source)
What to know before you sign up
LillyDirect is not a weight-loss program. It is Eli Lilly's own pharmacy channel, and the self-pay prices on its Zepbound page are the reference every brand-tirzepatide program in this table is measured against: $299 a month for the 2.5 mg starting dose in a vial or KwikPen, $399 for 5 mg, and $449 for 7.5 mg and above when you refill within 45 days, with a month defined as 28 days. Miss that refill window and the regular price applies, $499 for 7.5 mg and $699 for 10 mg and up. Foundayo, Lilly's daily pill, starts at $149 a month for the 0.8 mg dose and reaches $299 at the higher doses (at 14.5 mg and 17.2 mg only when you refill within 45 days; the 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026).
What LillyDirect does not provide is a prescriber. Step one on its page is "Ask your doctor to send your prescription to LillyDirect Pharmacy", and the find-a-doctor link goes to independent telehealth providers whose fees Lilly does not print and whose availability "varies by state and condition". So the fair comparison is LillyDirect's drug price plus whatever your own clinician or a telehealth visit costs, against a program's membership plus its drug price.
The single-dose vial is sold only through LillyDirect and only self-pay. The single-dose pen takes commercial insurance with a savings card that can bring the copay to $25, and government beneficiaries are excluded from that card. Every price here is a savings-program price that Lilly says it can amend or end at any time, so read the terms on the day you order.
Frequently asked questions
Do I need a prescription to buy Zepbound from LillyDirect?
Yes. LillyDirect is a pharmacy, not a clinic. Its page tells you to ask your doctor to send the prescription to LillyDirect Pharmacy in Indianapolis, and if you have no doctor it links to independent telehealth providers whose fees are not shown on Lilly's site and whose availability varies by state.
How much does Zepbound cost through LillyDirect?
On September 23, 2026 the self-pay price was $299 a month for the 2.5 mg vial or KwikPen, $399 for 5 mg and $449 for 7.5 mg through 15 mg when refilled within 45 days ($499 to $699 otherwise). A month is 28 days. The single-dose pen is an insurance product with a $25 copay card for eligible commercial plans.
Has the FDA or a regulator taken action against Eli Lilly?
Yes, on record as of September 23, 2026: three FDA warning letters dated September 9, 2025 about Zepbound promotional videos found false or misleading, and 2026 state attorney general suits in Delaware and Florida over insulin and diabetes-drug pricing. Two of them concern videos that promoted Zepbound through LillyDirect without risk information; none concerns LillyDirect's dispensing, and the FTC case library returned nothing.
Was this helpful?
Your feedback shapes what we cover next.
Thanks for letting us know.
If you found this useful, sign up for our newsletter to get more like this.
Thanks. What was missing?
Optional. We read every response.
Thanks.
We use this to prioritize the next round of edits.